vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Ranpak Holdings Corp. (PACK). Click either name above to swap in a different company.

Ranpak Holdings Corp. is the larger business by last-quarter revenue ($93.7M vs $89.1M, roughly 1.1× HARROW, INC.). On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 2.3%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 13.7%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...

HROW vs PACK — Head-to-Head

Bigger by revenue
PACK
PACK
1.1× larger
PACK
$93.7M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+31.0% gap
HROW
33.3%
2.3%
PACK
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
13.7%
PACK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
PACK
PACK
Revenue
$89.1M
$93.7M
Net Profit
$6.6M
Gross Margin
79.3%
39.0%
Operating Margin
17.5%
-1.0%
Net Margin
7.4%
Revenue YoY
33.3%
2.3%
Net Profit YoY
-2.2%
EPS (diluted)
$0.20
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
PACK
PACK
Q4 25
$89.1M
$93.7M
Q3 25
$71.6M
$83.6M
Q2 25
$63.7M
$77.8M
Q1 25
$47.8M
$77.6M
Q4 24
$66.8M
$91.6M
Q3 24
$49.3M
$78.6M
Q2 24
$48.9M
$72.8M
Q1 24
$34.6M
$72.5M
Net Profit
HROW
HROW
PACK
PACK
Q4 25
$6.6M
Q3 25
$1.0M
$-10.4M
Q2 25
$5.0M
$-7.5M
Q1 25
$-17.8M
$-10.9M
Q4 24
$6.8M
Q3 24
$-4.2M
$-8.1M
Q2 24
$-6.5M
$5.5M
Q1 24
$-13.6M
$-8.1M
Gross Margin
HROW
HROW
PACK
PACK
Q4 25
79.3%
39.0%
Q3 25
75.3%
41.1%
Q2 25
74.5%
37.1%
Q1 25
67.5%
39.8%
Q4 24
78.8%
45.2%
Q3 24
75.6%
43.8%
Q2 24
74.4%
43.5%
Q1 24
69.5%
44.6%
Operating Margin
HROW
HROW
PACK
PACK
Q4 25
17.5%
-1.0%
Q3 25
20.6%
-6.8%
Q2 25
17.9%
-12.5%
Q1 25
-23.5%
-10.3%
Q4 24
19.3%
1.5%
Q3 24
2.7%
-5.3%
Q2 24
3.1%
-7.1%
Q1 24
-20.0%
-6.6%
Net Margin
HROW
HROW
PACK
PACK
Q4 25
7.4%
Q3 25
1.4%
-12.4%
Q2 25
7.8%
-9.6%
Q1 25
-37.2%
-14.0%
Q4 24
10.1%
Q3 24
-8.6%
-10.3%
Q2 24
-13.2%
7.6%
Q1 24
-39.2%
-11.2%
EPS (diluted)
HROW
HROW
PACK
PACK
Q4 25
$0.20
$-0.11
Q3 25
$0.03
$-0.12
Q2 25
$0.13
$-0.09
Q1 25
$-0.50
$-0.13
Q4 24
$0.19
$-0.13
Q3 24
$-0.12
$-0.10
Q2 24
$-0.18
$0.07
Q1 24
$-0.38
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
PACK
PACK
Cash + ST InvestmentsLiquidity on hand
$72.9M
$63.0M
Total DebtLower is stronger
$250.0M
$401.9M
Stockholders' EquityBook value
$52.4M
$534.9M
Total Assets
$399.5M
$1.1B
Debt / EquityLower = less leverage
4.77×
0.75×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
PACK
PACK
Q4 25
$72.9M
$63.0M
Q3 25
$74.3M
$49.9M
Q2 25
$53.0M
$49.2M
Q1 25
$66.7M
$65.5M
Q4 24
$47.2M
$76.1M
Q3 24
$72.6M
$69.5M
Q2 24
$71.0M
$65.1M
Q1 24
$76.0M
$55.1M
Total Debt
HROW
HROW
PACK
PACK
Q4 25
$250.0M
$401.9M
Q3 25
$347.2M
$403.1M
Q2 25
$250.6M
$403.1M
Q1 25
$256.9M
$405.2M
Q4 24
$262.7M
$406.4M
Q3 24
$230.7M
$403.2M
Q2 24
$236.3M
$396.1M
Q1 24
$243.4M
$396.7M
Stockholders' Equity
HROW
HROW
PACK
PACK
Q4 25
$52.4M
$534.9M
Q3 25
$47.0M
$537.8M
Q2 25
$49.7M
$539.0M
Q1 25
$56.5M
$544.1M
Q4 24
$69.7M
$548.1M
Q3 24
$58.0M
$564.3M
Q2 24
$58.5M
$566.2M
Q1 24
$60.6M
$560.0M
Total Assets
HROW
HROW
PACK
PACK
Q4 25
$399.5M
$1.1B
Q3 25
$363.1M
$1.1B
Q2 25
$345.0M
$1.1B
Q1 25
$364.2M
$1.1B
Q4 24
$389.0M
$1.1B
Q3 24
$351.5M
$1.1B
Q2 24
$306.6M
$1.1B
Q1 24
$295.5M
$1.1B
Debt / Equity
HROW
HROW
PACK
PACK
Q4 25
4.77×
0.75×
Q3 25
7.39×
0.75×
Q2 25
5.05×
0.75×
Q1 25
4.55×
0.74×
Q4 24
3.77×
0.74×
Q3 24
3.98×
0.71×
Q2 24
4.04×
0.70×
Q1 24
4.02×
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
PACK
PACK
Operating Cash FlowLast quarter
$8.4M
$19.5M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
PACK
PACK
Q4 25
$8.4M
$19.5M
Q3 25
$16.6M
$8.5M
Q2 25
$-803.0K
$-3.6M
Q1 25
$19.7M
$-1.3M
Q4 24
$-17.8M
$6.5M
Q3 24
$3.0M
$10.1M
Q2 24
$-2.7M
$19.6M
Q1 24
$-4.6M
$5.2M
Free Cash Flow
HROW
HROW
PACK
PACK
Q4 25
$8.1M
Q3 25
$16.4M
Q2 25
$-969.0K
Q1 25
$19.5M
Q4 24
$-18.3M
Q3 24
$2.3M
Q2 24
$-3.1M
Q1 24
$-4.7M
FCF Margin
HROW
HROW
PACK
PACK
Q4 25
9.1%
Q3 25
22.9%
Q2 25
-1.5%
Q1 25
40.8%
Q4 24
-27.4%
Q3 24
4.8%
Q2 24
-6.3%
Q1 24
-13.6%
Capex Intensity
HROW
HROW
PACK
PACK
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.4%
Q4 24
0.8%
Q3 24
1.2%
Q2 24
0.7%
Q1 24
0.3%
Cash Conversion
HROW
HROW
PACK
PACK
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
3.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

PACK
PACK

Other$47.9M51%
Europe And Asia Segment$45.8M49%

Related Comparisons